Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme 5 selected

Guidance programme

Showing 1 to 50 of 137

TitleReference numberPublishedLast updated
Pegzilarginase for treating arginase-1 deficiency in people 2 years and overHST35
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2HST34
HIV testing: increasing uptake among people who may have undiagnosed HIVNG60
Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and overHST33
Burosumab for treating X-linked hypophosphataemia in children and young peopleHST8
Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type BHST32
Tobacco: preventing uptake, promoting quitting and treating dependenceNG209
Epilepsies in children, young people and adultsNG217
Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 yearsNG247
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndromeHST31
Sebelipase alfa for treating Wolman diseaseHST30
Velmanase alfa for treating alpha-mannosidosisHST29
Birch bark extract for treating epidermolysis bullosaHST28
Afamelanotide for treating erythropoietic protoporphyriaHST27
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiencyHST26
Onasemnogene abeparvovec for treating spinal muscular atrophyHST15
Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophyHST24
Lumasiran for treating primary hyperoxaluria type 1HST25
Asfotase alfa for treating paediatric-onset hypophosphatasiaHST23
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin geneHST22
Delirium: prevention, diagnosis and management in hospital and long-term careCG103
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and educationNG213
Advocacy services for adults with health and social care needsNG227
Self-harm: assessment, management and preventing recurrenceNG225
Social, emotional and mental wellbeing in primary and secondary educationNG223
Setmelanotide for treating obesity caused by LEPR or POMC deficiencyHST21
Reducing sexually transmitted infectionsNG221
Social work with adults experiencing complex needsNG216
Vaccine uptake in the general populationNG218
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and overHST20
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18
Integrated health and social care for people experiencing homelessnessNG214
Mental wellbeing at workNG212
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
Givosiran for treating acute hepatic porphyriaHST16
Looked-after children and young peopleNG205
Autism spectrum disorder in adults: diagnosis and managementCG142
Safeguarding adults in care homesNG189
Metreleptin for treating lipodystrophyHST14
Volanesorsen for treating familial chylomicronaemia syndromeHST13
Behaviour change: digital and mobile health interventionsNG183
Antenatal and postnatal mental health: clinical management and service guidanceCG192
Supporting adult carersNG150
Indoor air quality at homeNG149
Workplace health: long-term sickness absence and capability to workNG146
End of life care for adults: service deliveryNG142
Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutationsHST11
Patisiran for treating hereditary transthyretin amyloidosisHST10
Alcohol interventions in secondary and further educationNG135

Results per page

  1. 10
  2. 25
  3. 50
  4. All